Gufic Biosciences

354.60

+4.35 (1.24%) tick

BSE

Buy Sell

NSE BSE

Last updated on 9 May 2025 03:53 PM

Open Demat account

Returns

-2.82%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

3512.22

Earning Per Share

8.59

Dividend Yield

0.04%

P/E Ratio

32.96

P/B Ratio

6.12

Debt to Equity

0.76

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Gufic Biosciences (GBL) was incorporated in Jul'84. The Company is a result of a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 40-42 per share and then got GBL listed on BSE. Presently, the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Choksi and Gandhi family, the promoters of GBL, have a long-standing presence in the pharma industry.

Similar Companies

Laurus Labs

588.8 +2.05 (0.00%) tick

1Yr Returns

+37.29%

Piramal Pharma Limited

207.77 +1.76 (0.01%) tick

1Yr Returns

+39.19%

Suven Pharmaceuticals

1077.8 +17.60 (0.02%) tick

1Yr Returns

+64.2%

J.B.Chemicals & Pharma

1524.6 -19.40 (-0.01%) tick

1Yr Returns

-12.54%

Wockhardt

1224.3 -10.90 (-0.01%) tick

1Yr Returns

+132.66%